more about bleeding with Pradaxa (dabigatran) and Xarelto (rivaroxaban)

December 2012

You'll hear more about bleeding with Pradaxa (dabigatran) and Xarelto (rivaroxaban)...two new "anticoagulant" blood thinners.

Pradaxa has been linked to an alarming number of reports of bleeding...since it was approved 2 years ago.

This has some prescribers leaning away from Pradaxa...and sticking with warfarin to keep a patient's blood thin.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Vaccines more focus on proper vaccine storage
Antidepressants The new Forfivo XL (for-FIVE-oh, bupropion) will increase the chance of mix-ups among bupropion forms
Rheumatoid Arthritis Rayos, a new delayed-release prednisone
Interactions drug interaction alerts between methotrexate and "PPI" stomach acid reducers (omeprazole, pantoprazole, etc)
Gastroenterology the new drug, Linzess (lin-ZESS, linaclotide)
Side Effects more about bleeding with Pradaxa (dabigatran) and Xarelto (rivaroxaban)
Beta-Blockers changes in prescriptions for "beta-blockers" (propranolol, metoprolol, etc) being used for heart disease
Inhalers Tudorza Pressair (TU-door-za, aclidinium), for chronic obstructive pulmonary disease (COPD)
Diabetes debate about whether diabetes patients who don't use insulin benefit from monitoring their blood sugar
Anticoagulants increase in Xarelto (rivaroxaban) prescriptions
Gout rev up promotion of Uloric for managing gout
Vaccines Prevnar 13 vaccine will be used in certain ADULTS
Compounding new oversight of pharmacy compounding
Practice enjoy the holiday letter from our staff